SCHEMBL5823205

SCHEMBL5823205

C[C@](N)(c1ccccc1)c1nccc(-c2sc(N3CCNCC3)nc2-c2cccc(F)c2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 6/20 0.47
MAPK13 O15264 1/20 0.40
MAPK12 P53778 1/20 0.40
MAPK11 Q15759 1/20 0.40
MAPK14 Q16539 1/20 0.40
ALDH1A2 O94788 1/20 0.39
HTR6 P50406 2/20 0.38
RIPK2 O43353 1/20 0.38
BRAF P15056 1/20 0.37
EGFR P00533 1/20 0.36
HTR1A P08908 1/20 0.35
HTR1D P28221 1/20 0.35
HTR1B P28222 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR7 P34969 1/20 0.35
HTR2B P41595 1/20 0.35
CHEK1 O14757 1/20 0.35
GUSB P08236 1/20 0.35
CCNT1 O60563 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5823066 0.91 KCNH2 (0.42) KCNH2MAPK13MAPK12MAPK11MAPK14
SCHEMBL5817615 0.91 KCNH2 (0.57) KCNH2EGFR
SCHEMBL5820844 0.90 KCNH2 (0.41) KCNH2MAPK13MAPK12MAPK11MAPK14
SCHEMBL5818957 0.85 KCNH2 (0.43) KCNH2MAPK13MAPK12MAPK11MAPK14
SCHEMBL5820563 0.84 KMT2A (0.47) KCNH2HTR1AHTR7
SCHEMBL5813599 0.83 KCNH2 (0.51) KCNH2
SCHEMBL5818466 0.81 KCNH2 (0.49) KCNH2ALDH1A2HTR6RIPK2HTR1A
SCHEMBL5823207 0.80 MAPK14 (0.56) KCNH2MAPK13MAPK12MAPK11MAPK14
SCHEMBL5816216 0.79 EGFR (0.48) KCNH2EGFR
SCHEMBL5819107 0.77 ADORA2A (0.38) MAPK13MAPK12MAPK11MAPK14BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed